We continue to shape the future of the dialysis industry.
1 Outlook 2020 excl. special items. Special items are effects that are unusual in nature and have not been foreseeable or not foreseeable in size or impact at the time of giving guidance. Growth rates are based on the adjusted results 2019 including the effects of the operations of the NxStage acquisition and the IFRS 16 implementation.
2 Net income attributable to shareholders of Fresenius Medical Care AG & Co. KGaA.
3 Excluding investments in debt securities.
4 Results 2019: proposal to be approved by the Annual General Meeting on May 19, 2020.
5 Full-time equivalents.